首页> 外文期刊>PLOS Neglected Tropical Diseases >Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection
【24h】

Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection

机译:TcI / TcVI / TcII Chagas-Flow ATE-IgG2a在克氏锥虫感染的通用和基因型特异性血清学诊断中的性能

获取原文
       

摘要

Distinct Trypanosoma cruzi genotypes have been considered relevant for patient management and therapeutic response of Chagas disease. However, typing strategies for genotype-specific serodiagnosis of Chagas disease are still unavailable and requires standardization for practical application. In this study, an innovative TcI/TcVI/TcII Chagas Flow ATE-IgG2a technique was developed with applicability for universal and genotype-specific diagnosis of T. cruzi infection. For this purpose, the reactivity of serum samples (percentage of positive fluorescent parasites-PPFP) obtained from mice chronically infected with TcI/Colombiana, TcVI/CL or TcII/Y strain as well as non-infected controls were determined using amastigote-AMA, trypomastigote-TRYPO and epimastigote-EPI in parallel batches of TcI, TcVI and TcII target antigens. Data demonstrated that “α-TcII-TRYPO/1:500, cut-off/PPFP = 20%” presented an excellent performance for universal diagnosis of T. cruzi infection (AUC = 1.0, Se and Sp = 100%). The combined set of attributes “α-TcI-TRYPO/1:4,000, cut-off/PPFP = 50%”, “α-TcII-AMA/1:1,000, cut-off/PPFP = 40%” and “α-TcVI-EPI/1:1,000, cut-off/PPFP = 45%” showed good performance to segregate infections with TcI/Colombiana, TcVI/CL or TcII/Y strain. Overall, hosts infected with TcI/Colombiana and TcII/Y strains displayed opposite patterns of reactivity with “α-TcI TRYPO” and “α-TcII AMA”. Hosts infected with TcVI/CL strain showed a typical interweaved distribution pattern. The method presented a good performance for genotype-specific diagnosis, with global accuracy of 69% when the population/prototype scenario include TcI, TcVI and TcII infections and 94% when comprise only TcI and TcII infections. This study also proposes a receiver operating reactivity panel, providing a feasible tool to classify serum samples from hosts infected with distinct T. cruzi genotypes, supporting the potential of this method for universal and genotype-specific diagnosis of T. cruzi infection.
机译:不同的克鲁斯锥虫基因型被认为与南美锥虫病的患者管理和治疗反应有关。但是,Chagas疾病的基因型特异性血清诊断的分型策略仍然不可用,需要针对实际应用进行标准化。在这项研究中,开发了一种创新的TcI / TcVI / TcII Chagas Flow ATE-IgG2a技术,该技术适用于克氏锥虫感染的通用和基因型特异性诊断。为此目的,使用amstigote-AMA测定了从慢性感染了TcI /哥伦比亚,TcVI / CL或TcII / Y菌株的小鼠以及未感染的对照中获得的血清样品的反应性(阳性荧光寄生虫百分比-PPFP)。平行批次的TcI,TcVI和TcII靶抗原中的锥虫纲-TRYPO和淫母纲-EPI。数据表明,“α-TcII-TRYPO/ 1:500,临界值/ PPFP = 20%”表现出了广泛诊断克氏锥虫感染的出色性能(AUC = 1.0,Se和Sp = 100%)。属性组合集“α-TcI-TRYPO/ 1:4,000,临界值/ PPFP = 50%”,“α-TcII-AMA/ 1:1,000,临界值/ PPFP = 40%”和“α- TcVI-EPI / 1:1,000,临界值/ PPFP = 45%”显示出良好的隔离TcI /哥伦比亚,TcVI / CL或TcII / Y株感染的能力。总体而言,感染了TcI / Colombiana和TcII / Y菌株的宿主显示出与“α-TcITRYPO”和“α-TcIIAMA”相反的反应模式。感染TcVI / CL菌株的宿主表现出典型的交错分布模式。该方法对基因型特异性诊断表现出良好的性能,当总体/原型方案包括TcI,TcVI和TcII感染时,整体准确性为69%,而仅包括TcI和TcII感染时为94%。这项研究还提出了一个接收器操作性反应小组,提供了一种可行的工具来对感染了不同克鲁斯氏菌基因型的宿主的血清样本进行分类,从而支持该方法对克鲁斯氏菌感染的普遍性和基因型特异性诊断的潜力。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号